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Abstract
The opioid crisis has highlighted the importance of improving patients’ access to behavioral
treatments for chronic pain and addiction. What is not known is if patients are interested in
receiving these treatments. In this cross-sectional study, over 1000 participants with chronic pain
were surveyed using an anonymous online questionnaire on Amazon Mechanical Turk (Mturk)
to investigate participants’ use of and interest in pharmacological and behavioral treatments for
chronic pain and addiction. Participants also indicated whether their doctor had recommended
these treatments. The majority of participants reported using medication for their pain (83.19%)
and that their doctor recommended medication (85.05%), whereas fewer participants reported
using (67.45%) and being recommended to (62.82%) behavioral treatments. We found 63.67%
of participants screened positive for possible opioid misuse; those who screened positive were
more interested in receiving behavioral treatments than those who did not screen positive.
Participants who received treatment recommendations were more likely to be interested in
receiving those treatments as compared to participants who did not. The results suggest that
recommendations for behavioral treatments and interest in those treatments are related. Results
also suggest that patients endorsing behaviors consistent with opioid misuse are interested in
behavioral treatments.
Perspective: This study provides information around chronic pain patients’ treatment interests,
treatment receipt, and recommendation receipt for behavioral pain management and addiction
treatment. This study could help facilitate communication between patients and doctors
regarding available treatments for chronic pain and pain treatment-related addiction problems.
Key words: Chronic pain, behavioral treatment, opioid misuse, addiction, treatment preferences
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Introduction
Chronic pain is one of the most debilitating, difficult to treat, chronic health conditions
and affects at least 20% of the American adult population.7 In addition to the direct impact on
quality of life via health consequences, chronic pain is widely believed to be causally related to
the current opioid epidemic.24
Opioid pain medications are one of the most frequently used treatments for chronic
pain,16 despite limited evidence of their long-term efficacy.10,21 Risks of opioid pain medication
include abuse, addiction, and overdose.10 As many as 62% of patients with chronic pain who are
prescribed opioids misuse them.39
Despite opioids being a commonly used treatment for chronic pain, clinical practice
guidelines strongly emphasize behavioral approaches as first-line treatments for chronic
pain.9,10,34 There is ample evidence to support the efficacy of behavioral approaches to treat pain,
including cognitive behavioral therapy (CBT),18,30 health coaching,38 behavioral activation28 and
mindfulness.18
There are likely numerous reasons for the common use of opioid pain medication over
behavioral approaches, including pressure on physicians to provide rapid pain relief,27 economic
and time demands during medical appointments,23 and barriers to accessing behavioral
treatments, such as high cost, variable accessibility, and low motivation.2 For instance, patients
may not be able to locate a behavioral health provider with expertise in chronic pain, insurance
may not be accepted, and behavioral treatments often require practice between sessions for
maximal benefit. In addition, physicians report concerns about negative interactions with patients
if they recommend behavioral treatments.17
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Both patients and providers may perceive discussions around chronic pain treatment as
uncomfortable, with providers feeling pressure to prescribe opioid medication, and patients
reporting concerns that their doctors view them as drug-seeking.26 This mutual discomfort and
lack of a shared understanding of patients’ pain treatment preferences indicates that there is a
need for more information regarding patients’ preferences. For instance, it is unknown whether
there is an association between doctors’ recommendations and patients’ interest in behavioral
treatments. This additional understanding could inform a more candid and effective conversation
about pain treatment. Further, it is not known whether patients misusing opioids are less
interested in behavioral approaches, as is commonly perceived by physicians.3 Information about
patient interests and preferences is needed to guide public health approaches to increase use of
behavioral treatments for chronic pain.
The aims of the current study are to better understand patients’ receipt of
recommendations for chronic pain treatments from their doctor, as well as their interest in and
use of treatments for chronic pain. We were interested in understanding whether there is a
relationship between doctor recommendation for a treatment and patients’ interest in this
treatment. We also aimed to determine whether patients misusing opioids are less likely to be
interested in behavioral treatments. We hypothesized that (a) more patients will have received
and have been recommended to receive medication treatment than behavioral treatment; (b) there
will be a positive association between providers recommending behavioral treatments and
patients’ interest in behavioral treatments; and (c) patients who report misusing opioids will be
less interested in behavioral treatments than medication.
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Methods
Participants
Since we were interested in understanding the treatment interest of a large community
sample of chronic pain patients, including those who may be misusing opioids, participants were
recruited through Amazon’s Mechanical Turk (Mturk). Mturk provides a user-friendly interface
for participants and allows researchers to collect data from a diverse participant pool.4 Previous
research has found participants on Mturk are willing to admit to higher rates of addiction,36
perhaps due to the anonymous nature of the format. Mturk has been found to be reliable and
valid for populations with health concerns,35 including addiction.20 All Mturk workers were able
to access the survey, but screening questions were included at the beginning of the survey to
ensure respondents met the inclusion criteria. Those that did not endorse the inclusion criteria
were directed to a thank you page and exited out of the survey.
A total of 1399 participants accessed the study over a period of approximately one week
during August of 2018. Participants were allowed to proceed with the survey if they answered
“Yes” to all of the following inclusion criteria questions: “Are you over the age of 18?”; “Do you
have chronic pain?”; “Do you receive your healthcare in the United States?” Based on these
criteria, 349 participants were excluded, leaving a final study sample of 1050 participants (550
women, 485 men, and 4 other; 12 participants did not identify a gender). More detailed
demographic information about participants is reported in Table 1.

CHRONIC PAIN AND ADDICTION TREATMENT PREFERENCES

Demographic

Category

Age
Gender

Work Status

Disability benefits

37.50 (11.94)
Female

52.38% (550)

Male

46.19% (485)

Other

0.38% (4)

Working (Full or Part time)

73.42% (771)

Student (Full or Part time)

6.38% (67)

Not working

27.05% (284)

Disability benefits (% yes)

20.38% (214)

Level of education High school/GED/Trade school/Some
college

Marital status

Ethnicity

Race

Military Service

Community

Mean (SD) / % (N)

41.90% (440)

College graduate or higher

57.90% (608)

Married/living as married

51.71% (543)

Not married

47.71% (501)

Hispanic/Latino

11.90% (125)

Not Hispanic/Latino

87.33% (917)

American Indian

1.24% (13)

Asian

5.05% (53)

Native Hawaiian/Pacific Islander

0.19% (2)

Black/African American

9.05% (95)

White

80.48% (845)

More than one race

1.90% (20)

Other

1.52% (16)

No

87.62% (920)

Yes

12.29% (129)

Urban

65.05% (683)

Rural

34.38% (361)

7
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Table 1. Descriptive data for sample.
Note: Totals vary, as not all participants completed every question and some questions allowed
for multiple responses.
Measures
Behavioral treatment measures. Survey items were developed by the research team
based on clinical consensus of treatments typically indicated for chronic pain and available in the
Veterans Affairs healthcare system. The survey included brief descriptions of behavioral and
pharmacological treatments for chronic pain and addiction including cognitive behavioral
therapy (CBT), health coaching, behavioral activation, mindfulness, positive practice,
medication, and addiction treatment (see Appendix A). Participants were asked to indicate if they
had received each of these treatments in the past (Y/N), whether their doctor had recommended
each treatment (Y/N), and whether they were interested in receiving each treatment (Yes very
interested; Somewhat interested; Not very interested; Not interested at all).
Multidimensional Pain Inventory. The West Haven-Yale Multidimensional Pain
Inventory19 is a well-validated self-report measure of important dimensions of the experience of
people with chronic pain. While all the participants in the sample endorsed chronic pain,
respondents were asked to rate pain level at the present moment, severity during the past week,
and suffering due to pain on a scale of 0-6, with 0 = not severe at all and 6 = extremely severe.
Pain Disability Index. The Pain Disability Index33 is a self-report instrument used to
assess the degree to which chronic pain interferes with various daily activities. Participants were
asked to answer how much their pain negatively impacts their life in the following areas:
family/home responsibilities, recreation, social activity, occupation, sexual behavior, self-care,
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and life-support activities. Respondents answered on a scale of 0-10, with 0 = no disability and
10 = worst disability.
Self-report measures of medication use. Respondents were asked whether they are
currently taking any medications for their chronic pain (Y/N) and whether they are taking any
opioid medications (Y/N; e.g., Hydrocodone, Oxycodone, Morphine, Fentanyl, Codeine,
Methadone, Meperidine, Propoxyphene, and Tramadol). Brand names for each medication were
provided as examples (e.g., Lorcet, Vicodin, Percocet, Dilaudid, Opana, Demerol, etc.).
Current Opioid Misuse Measure (COMM). Current Opioid Misuse Measure
(COMM)5 is a 17-item well-validated self-report questionnaire of various behaviors, emotional,
and psychiatric problems related to opioid misuse (e.g., In the past 30 days, how often have you
taken your medications differently from how they are prescribed?). Items are rated from 0
(never) to 4 (often) with a total maximum score of 68. A score of “9” or higher is considered
positive for risk of opioid misuse. The full 17-item COMM includes a question around thoughts
of self-harm, which was removed because this research was conducted anonymously and we had
no ability to follow up on suicidal ideation,8 resulting in a maximum possible score of 64. As a
result, a cutoff score of “8” to indicate risk of opioid misuse was used for data analysis in the
present study. The Cronbach's alpha among our sample was .771, which is considered
acceptable.15 For comparison, Martel and colleagues assessed for opioid misuse among patients
with chronic pain and found an alpha coefficient of .74 after removing items related to
experience of psychiatric issues.25
Patient Health Questionnaire-2 (PHQ-2). The PHQ-222 is a two-item screen for
depression. It inquires, “Over the last 2 weeks, how often have you been bothered by the
following problems? 1. Little interest or pleasure in doing things. 2. Feeling down, depressed or
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hopeless." Items are rated from 0 (Not at all) to 3 (Nearly every day) with a total maximum score
of 6. A positive depression screen is indicated by a score of “3” or higher.
Demographic questions. Respondents were asked to report their age, gender, ethnicity,
race, education level, marital status, employment status, military service, disability benefit status
and whether they lived in a rural or urban area (see Table 1).
Procedures
This study was a cross-sectional, between-subjects design. All participants electronically
reviewed and affirmed their understanding of an informed consent form prior to study
participation, and all procedures were approved by the SUNY Albany Institutional Review
Board. The survey took about 15 minutes to complete. The questionnaire responses were housed
on PsychData to ensure no identifying information, such as IP addresses, was associated with
participants’ responses.29 At the end of the survey, participants were given a completion code to
enter into Mturk for payment. Eligible participants who completed the survey were compensated
$1.00 for their time.
Data analysis
All data were analyzed using SPSS v.25. Data were checked for low response rate (<20%
of items completed for any one measure) and no cases were excluded. Descriptive data for
categorical variables were presented as percentage responding “yes,” and were analyzed using
chi-square tests. We examined bivariate correlations between demographic and clinical variables,
interest in treatments, recommendations for treatments, and receipt of treatments.
For chi-square analyses including respondents’ interest in treatments, responses of “Yes
very interested” and “Somewhat interested” were grouped and re-coded as “Interested.”
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Responses of “Not very interested” and “Not interested at all” were grouped and re-coded as
“Not interested.”
Results
Descriptive Statistics
Participants were between 19 and 81 years old (M = 37.50, SD = 11.94). About half of
the sample were female (52.38%). A high percentage of our sample were white (80.48%), had a
college degree or higher (57.9%), and working (73.42%; Table 1).
The participants’ responses on the PHQ-2 indicated that 46% of our sample scored above
the cutoff for positive depression screen, indicated by a score of “3” or above. The mean score
on the PHQ-2 was 2.55 (SD = 1.70), out of a maximum of 6.
The average level of pain in the present moment was 3.21 (SD = 1.25) out of 6 and 3.76
(SD = 1.20) out of 6 in the past week. The average suffering experienced due to pain was 3.75
(SD = 1.22) out of 6. The pain impairment index showed an average pain disability of 4.61 (SD =
2.25) out of 10.
There was a high rate of endorsement of behaviors associated with opioid misuse:
63.67% of those receiving opioid treatment screened positive for being at risk of opioid misuse,
indicated by a score of “8” or above. The mean score on the COMM was 28.17 (SD = 13.43), out
of a maximum of 64.
Receipt of Treatments
Overall, 32.55% of participants reported having received none of the behavioral
treatments indicated on the survey. Of the participants who had received any behavioral
treatment (67.45%), on average they received 2.32 (SD = 1.26) behavioral treatments. Most
participants received medication for their chronic pain (83.19%). Table 2 shows the percent of
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participants who received each of the treatments. The least received treatments were addiction
treatment (15.27%) and behavioral activation (23.00%) and the most received treatments were
medication (83.19%) and health coaching (37.04%).
Treatment

Received
Treatment
(%)

Provider
Recommended
Treatment
(%)

Interest in receiving treatment
% Very
interested

%
Somewhat
Interested

% Not
very
interested

% Not at
all
interested

CBT

36.49%

33.91%

22.67%

42.44%

18.31%

16.57%

Health
Coaching

37.04%

41.08%

29.22%

36.16%

18.80%

15.81%

Behavioral
Activation

23.00%

22.93%

24.10%

35.37%

21.19%

19.34%

Mindfulness

32.98%

27.13%

27.71%

35.56%

18.90%

17.83%

Positive
Practice

28.45%

28.03%

26.59%

35.93%

19.75%

17.73%

Addiction
Treatment

15.27%

16.02%

8.11%

12.93%

17.28%

61.68%

Medication

83.19%

85.05%

40.00%

33.69%

15.63%

10.68%

Table 2. Receipt, recommendation for, and interest in treatments.
Recommendations for Treatments
Overall, 37.18% of participants reported receiving no recommendations for behavioral
treatments. Of the participants who received any behavioral treatment recommendations
(62.82%), on average they received recommendations for 2.11 (SD = 1.50) behavioral
treatments. Most participants reported receiving recommendations for medication (85.05%).
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Table 2 shows the percent of participants who received recommendations for each of the
treatments. The least recommended treatments were addiction treatment (16.02%) and behavioral
activation (22.93%) and the most recommended treatments were medication (85.05%) and health
coaching (41.08%).
Interest in Treatments
Overall, 89.05% of participants reported being very or somewhat interested in receiving
at least one behavioral treatment and 73.69% of participants reported being very or somewhat
interested in medication. Participants reported being interested in an average of 3.15 (SD = 1.70)
behavioral treatments. Table 2 shows the percent of participants interested in each of the
treatments. The behavioral treatments that participants reported the most interest in were health
coaching (65.38%), mindfulness (63.27%), and positive practice (62.52%).
Bivariate Correlations Between Variables
Bivariate correlations show significant positive associations between positive depression
screen, pain severity, pain disability, and behavioral treatment interest, recommendation, and
receipt. There was not a consistent relationship between age, education or gender and interest,
recommendation, or receipt of treatments. Table 3 shows the bivariate correlations between age,
gender, education, depression, disability, pain severity, pain disability, and interest in treatment,
treatment recommendations, and treatment receipt.

Receipt of Health
Coaching

Recommendation
for CBT

Interest in CBT

Receipt of CBT

Note. Significance levels: * p < 0.05; ** p < 0.01.

Table 3. Bivariate correlations between age, gender, education, depression, disability, severity,
and receipt of, interest in, and recommendation for various treatments.

.162** .180** .178** .141** .133** .128** .159** .192** .157** .080* .135** .105** .063* .170** 0.031 .113** .169** .1

Interest in Health
Coaching

Severity
(MPI)

Recommendation
for Health

.274** .214** .282** .151** .147** .167** .234** .223** .231** .131** .159** .204** 0.015 .183** -0.012 .224** .302** .2

Coaching
of
Receipt
Behavioral
Activation
in
Interest
Behavioral

Disability
(PDI)

Activation
Recommendation
for Behavioral
Activation
of
Receipt
Mindfulness

.224** .193** .262** .085** .163** .113** .151** .224** .150** .117** .170** .171** -0.010 .144** -0.036 .156** .245** .1

Interest in
Mindfulness

Depression
(PHQ-2)

Recommendation
for Mindfulness

.187** .098** .187** .072* .106** .070* .107** .106** .151** .137** .087** .158** -.089** 0.025 -.072* .096** .171** .1

Receipt of
Medication

Level of
education

Interest in
Medication

.065* 0.023 0.027 0.056 -0.023 .089** .088** -0.050 .158** 0.028 -0.018 .098** -0.042 0.047 -0.054 .093** .180** .1

Recommendation
for Medication

Gender

Receipt of
Addiction

-.079* -.116**-.175** -0.022 -.066* -.095**-.098** -0.020 -.107**-.106** -.065* -.163** 0.057 -0.035 0.033 -.082**-.174**-.

Treatment
in
Interest
Addiction
Treatment
Recommendation

Age
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Interest in Treatment for Patients Recommended to Treatment vs. Not Recommended to

Treatment

Chi-square analysis showed that participants who reported having received a

recommendation for a treatment were more interested in receiving that treatment as compared to
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those who did not receive a recommendation for that treatment. The chi-square was significant
for all treatments, including both behavioral and pharmacological treatments (Figure 1).

Figure 1. Percent of participants interested in treatments by provider recommendation/no provider
recommendation. * indicates p = .0001.

Interest in Treatment for Patients Misusing Opioids vs. Not Misusing Opioids
Chi-square analysis showed that participants receiving opioids who screened positive for
opioid misuse were significantly more interested in behavioral treatments, including addiction
treatment, as compared to those not misusing opioids. There was no difference in interest in
medication treatment for patients who screened positive for opioid misuse as compared to those
who did not screen positive for opioid misuse (Figure 2).
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Figure 2. Percent of participants interested in treatments by risk of opioid misuse/no risk of opioid
misuse. * indicates p = .0001.

Discussion
This study aimed to understand recommendations by doctors, as well as patients’ interest
in, and actual treatment receipt across a range of approaches for chronic pain among a large
sample of community respondents with chronic pain. Additional aims were to understand
whether treatment interest varied by doctor recommendation or risk of opioid misuse.
We found that patients with chronic pain were overwhelmingly interested in receiving
behavioral treatments, with higher rates of interest in receiving these treatments than actual
receipt of these treatments or receipt of recommendations for these treatments. Of the behavioral
treatments, individuals were most interested in health coaching, mindfulness and positive
practice.
Importantly, we found that provider recommendations were associated with treatment
interest: respondents whose doctors recommended treatments were also more likely to be
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interested in receiving these treatments as compared to those who did not receive a
recommendation. This was true for all treatments, including addiction treatment. Behavioral
treatments that were recommended with the highest frequency were cognitive-behavioral therapy
and health coaching, perhaps reflecting greater awareness and availability of these treatments as
compared to the others. While we are unable to determine the direction of the relation between
provider recommendation and patient treatment interest due to the cross-sectional nature of this
study, findings are supportive of the hypothesis that provider recommendations may be
associated with increased patient interest in receiving the intervention.
Importantly, respondents who misused opioids were more interested in receiving
behavioral treatments for their pain and also more interested in receiving addiction treatment as
compared to those who were not misusing opioids. Patients with chronic pain who misuse
opioids are often negatively perceived as resistant to behavioral pain and addiction treatments in
the healthcare and broader community.6 Our findings indicate, however, that patients who show
signs of opioid misuse are interested in behavioral treatment options. This may reflect that opioid
medication is not effectively managing pain and thus patients are interested in other forms of
therapy to replace or serve as adjuncts to medication therapy. Our findings also suggest that
patients who endorse behaviors associated with opioid misuse are likely to be receptive to
addiction treatment recommendations.
Our data suggest public health efforts do not need to focus on convincing patients to
consider behavioral treatments. Rather, public health efforts are needed to train providers to
more frequently and perhaps more effectively make recommendations for behavioral treatments.
While, in general, provider recommendations and interest are associated, not all patients who
were recommended a treatment were interested. Previous research finds that when not delivered

CHRONIC PAIN AND ADDICTION TREATMENT PREFERENCES

18

correctly, a recommendation for behavioral treatments can feel like the provider is discrediting or
misunderstanding the patient’s pain, or implying the pain is “all in their head”.12,13 Public health
efforts are likely also needed to increase the availability of these treatments. Our data found that
few participants received these behavioral treatments and previous research supports the multiple
barriers of treatments receipt for pain.2
Moreover, our data suggest that both patients and providers should be apprised of the full
menu of treatment options for chronic pain, including integrative pharmaceutical and behavioral
approaches. Previous research suggests that patients typically benefit from interdisciplinary
approaches to pain management, including lifestyle modification, movement therapies, and
mind-body based treatments.31 Patients’ behavioral treatment preferences did not always exactly
mirror doctor recommendations, and those who had received behavioral recommendations
typically noted interest in several approaches, suggesting that there may be room for discussion
of multiple approaches to pain management. Discussing these multiple approaches may
ultimately increase receipt, as patients cite having a wide array of treatment options as a
facilitator to using behavioral treatments for chronic pain.2 In our sample, depression, pain
severity and pain-related disability were related to interest, recommendation, and receipt of
behavioral treatments. This means that depression, pain severity, and pain-related disability may
be important indicators for behavioral treatment interest and use.
Strengths of this study include data being collected via Mturk, which is an anonymous
online method that may have facilitated more honest and genuine responses regarding treatment
interest and risk of opioid misuse.36 Mturk also has limitations. While a large community sample
was used, there may be characteristics unique to this sample which limit generalizability to the
broader population. Research has shown that Mturk samples tend to be younger, more educated,
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and have higher rates of depression than nationally representative sources,36 and this finding may
be accurate for our sample as well. For example, our sample may have been younger, with more
education, and a greater proportion reporting moderate or worse pain when compared to a
nationally-representative survey such as the Medical Expenditure Panel Survey.32 Additionally,
nearly half of the present study’s sample scored at or above the cutoff on a brief depression
screen. Although positive screen does not necessarily equate to diagnosis, this is a rate closer to
the prevalence of depression found in pain clinics or inpatient pain programs as compared to the
general population.1 In a study of Veterans’ pain treatment preferences, those with higher
educational attainment and worse mental health symptoms were more likely to have used
psychological/behavioral modalities.11 As such, this sample may represent a subgroup of patients
with pain and depression symptoms closer to a clinical population, which may, in turn, affect
treatment preferences.
Another limitation was that we included select behavioral interventions and thus, did not
evaluate interest in other approaches to chronic pain such as physical therapy and diet
modifications. Also, this was a cross-sectional study and thus we cannot draw definitive
conclusions regarding the influence of treatment interest on subsequent receipt. Future research
could examine whether pain severity or disability interact with opioid use/misuse to predict
treatment recommendation, interest, and receipt, as these examinations were beyond the scope of
this paper. While this study focused on individual interest in treatment, it should be noted that
there are multiple factors affecting the use of and access to chronic pain treatment modalities,
including changes in approaches to pain and pain treatment (i.e., biopsychosocial framework,
biomedical model, etc.),14 as well as shifts in funding and public health policy.37 These should be
explored in future studies.
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Overall, this study underscores the importance of developing, discussing and
recommending alternative treatment approaches to the management of chronic pain. Our findings
suggest a high rate of interest in non-pharmacological, behavioral treatments, which was even
more prevalent among patients whose providers recommended these treatments and among
patients misusing opioids. Rather than assume patients prefer medication for chronic pain,
providers should explore a broad range of behavioral treatment options with patients.
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Table 1. Descriptive data for sample.
Table 2. Receipt, recommendation for, and interest in treatments.
Table 3. Bivariate correlations between age, gender, education, depression, disability, severity
and interest in, receipt of, and recommendation for various treatments.
Figure Legend
Figure 1. Percent of participants interested in treatments by provider recommendation/no
provider recommendation.
Figure 2. Percent of participants interested in treatments by risk of opioid misuse/no risk of
opioid misuse.
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Appendix A
Descriptions of Treatments
Cognitive Behavioral Therapy: There are many things that impact your chronic pain including
your emotions, how you think about your pain, and how you behave in response to your pain.
This treatment is a time-limited, weekly treatment that teaches you how to relax your body,
manage your emotions, and change your thoughts and behaviors to reduce your pain.
Health Coaching: Did you know that how you take care of your health can also impact your
pain? This treatment teaches you about how eating well, exercising, improving your sleep and
other health changes can reduce your pain. It also teaches you how to make these changes.
Behavioral Activation: Pain makes it hard to do the things we want and need to do. Many
people with chronic pain have a hard time maintaining relationships, keeping up with
housework, and doing hobbies. This treatment helps people with chronic pain regain control over
their life by teaching them strategies to increase the activities they like or need to do, despite
having pain.
Mindfulness: Pain makes it hard to enjoy the present moment, and often people find themselves
being overwhelmed by thoughts about their pain. This treatment helps people with chronic pain
remain focused on the present moment, and become aware of their thoughts and body in a nonjudgmental manner that fosters acceptance.
Medication: Certain medications can relieve the intensity of pain symptoms when taken as
prescribed by your doctor.
Addiction Treatment: Treatment can help with addiction to medication, alcohol or other
substances.
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Positive Practice: Many treatments for pain focus on alleviating pain symptoms or identifying
unhelpful thoughts and behaviors that can make pain worse. In contrast, a positive psychological
treatment approach focuses on building core human strengths and values that promote overall
well-being, even when you have pain. Examples of positive practices include retraining your
brain to notice and appreciate good things in your daily life, expressing gratitude, practicing
kindness, and identifying and using your own strengths (e.g., bravery, fairness, curiosity). These
practices can be cultivated in the context of counseling or independently, using self-help
resources.

